Integrated Filing — IndAS



General information about company

Scrip Code 543220
NSE Symbol MAXHEALTH
MSEI Symbol NOTLISTED
ISIN INE027H01010
Name of company Max Healthcare Institute Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 30-10-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 23-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Medical and Healthcare Services
Start date and time of board meeting 30-10-2026   12:50:00
End date and time of board meeting 30-10-2026   14:35:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 18-03-2026
Indicate Company website link for updated RPT policy of the Company https://d35oenyzp35321.cloudfront.net/RPT_Policy_2a10152cff.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No default on loans and debt security.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 84,197.00 1,62,489.00
Other income 4,911.00 14,121.00
Total income 89,108.00 1,76,610.00
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 18,144.00 36,828.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (57.00) (248.00)
(d) Employee benefit expense 14,829.00 29,422.00
(e) Finance costs 1,372.00 2,579.00
(f) Depreciation, depletion and amortisation expense 3,877.00 7,537.00
(f) Other Expenses
1 Professional and consultancy fee 18,124.00 35,092.00
2 Other expenses 10,204.00 20,194.00
Total other expenses 28,328.00 55,286.00
Total expenses 66,493.00 1,31,404.00
3 Total profit before exceptional items and tax 22,615.00 45,206.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 22,615.00 45,206.00
6 Tax expense
7 Current tax 6,065.00 11,784.00
8 Deferred tax (283.00) (171.00)
9 Total tax expenses 5,782.00 11,613.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 16,833.00 33,593.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 16,833.00 33,593.00
17 Other comprehensive income net of taxes 789.00 354.00
18 Total Comprehensive Income for the period 17,622.00 33,947.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 97,331.00 97,331.00
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 1.73 3.45
Diluted earnings (loss) per share from continuing operations 1.72 3.43
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.73 3.45
Diluted earnings (loss) per share from continuing and discontinued operations 1.72 3.43
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) For Notes, kindly refer PDF file of Financial Results available on stock exchanges website viz. www.bseindia.com & www.nseindia.com.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 1,43,548.00
Capital work-in-progress 62,734.00
Investment property 466.00
Goodwill 1,31,935.00
Other intangible assets 2,13,978.00
Intangible assets under development 3,869.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 3,10,087.00
Trade receivables, non-current 7,348.00
Loans, non-current 1,33,379.00
Other non-current financial assets
1 Other financial assets 24,874.00
Total of other non-current financial assets 24,874.00
Total non-current financial assets 4,75,688.00
Deferred tax assets (net) 0.00
Other non-current assets
1 Other non-current assets 17,477.00
2 Income tax assets (net) 1,707.00
Total of other non-current assets 19,184.00
Total non-current assets 10,51,402.00
2 Current assets
Inventories 3,320.00
Current financial asset
Current investments 0.00
Trade receivables, current 49,785.00
Cash and cash equivalents 33,275.00
Bank balance other than cash and cash equivalents 155.00
Loans, current 3,987.00
Other current financial assets
Total of other current financial assets 3,313.00
Total current financial assets 90,515.00
Current tax assets (net)
Other current assets
1 Other current assets 3,153.00
Total of other current assets 3,153.00
Total current assets 96,988.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 11,48,390.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 97,331.00
Other equity 8,14,528.00
Total equity attributable to owners of parent 9,11,859.00
Non controlling interest
Total equity 9,11,859.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 1,03,805.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
Total of other non-current financial liabilities
Total non-current financial liabilities 1,03,805.00
Provisions, non-current 5,647.00
Deferred tax liabilities (net) 51,023.00
Deferred government grants, Non-current
Other non-current liabilities
1 Other non-current liabilities 403.00
Total of other non-current liabilities 403.00
Total non-current liabilities 1,60,878.00
Current liabilities
Current financial liabilities
Borrowings, current 12,385.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 252.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 31,733.00
Total Trade payable 31,985.00
Other current financial liabilities
1 Other financial liabilities 20,691.00
Total of other current financial liabilities 20,691.00
Total current financial liabilities 65,061.00
Other current liabilities 5,340.00
1 Other current liabilities 5,340.00
Total of other current liabilities 5,340.00
Provisions, current 5,252.00
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 75,653.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 2,36,531.00
Total equity and liabilites 11,48,390.00
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block

Textual Information(1) For Notes, kindly refer PDF file of Financial Results available on stock exchanges website viz. www.bseindia.com & www.nseindia.com.



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of defined benefit plans 36.00 99.00
Total Amount of items that will not be reclassified to profit and loss 36.00 99.00
2 Income tax relating to items that will not be reclassified to profit or loss 9.00 25.00
3 Amount of items that will be reclassified to profit and loss
1 Fair value changes on derivatives designated as cash flow hedge 1,018.00 374.00
Total Amount of items that will be reclassified to profit and loss 1,018.00 374.00
4 Income tax relating to items that will be reclassified to profit or loss 256.00 94.00
5 Total Other comprehensive income 789.00 354.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 45,206.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 2,343.00
Adjustments for decrease (increase) in inventories (248.00)
Adjustments for decrease (increase) in trade receivables, current (8,475.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (1,750.00)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 1,501.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 4,488.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 7,537.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 557.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current (225.00)
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 2.00
Adjustments for dividend income 0.00
Adjustments for interest income 12,874.00
Adjustments for share-based payments 1,878.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 589.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (4,677.00)
Net cash flows from (used in) operations 40,529.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 7,976.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 32,553.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 47,464.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 56.00
Purchase of property, plant and equipment 18,748.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 12,445.00
Cash receipts from repayment of advances and loans made to other parties 2,775.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 11,573.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (32.00)
Net cash flows from (used in) investing activities (64,285.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 1,434.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 39,881.00
Repayments of borrowings 6,626.00
Payments of lease liabilities 879.00
Dividends paid 19,437.00
Interest paid 2,518.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 11,855.00
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (19,877.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (19,877.00)
Cash and cash equivalents cash flow statement at beginning of period 53,152.00
Cash and cash equivalents cash flow statement at end of period 33,275.00





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Max Healthcare Institute Limited Alexis Multi-Speciality Hospital Private Limited Wholly - owned subsidiary Any other transaction Repayment of loans advances given to subsidiary - 1,500.00 0.00 0.00 Textual Information(1)
2 Max Healthcare Institute Limited Alexis Multi-Speciality Hospital Private Limited Wholly - owned subsidiary Interest received - 30.92 0.00 0.00
3 Max Healthcare Institute Limited Alexis Multi-Speciality Hospital Private Limited Wholly - owned subsidiary Any other transaction Lease rental expense - 1.52 0.00 0.00
4 Max Healthcare Institute Limited Alexis Multi-Speciality Hospital Private Limited Wholly - owned subsidiary Any other transaction Borrowings from subsidiaries - 1,000.00 0.00 0.00
5 Max Healthcare Institute Limited Alexis Multi-Speciality Hospital Private Limited Wholly - owned subsidiary Any other transaction Finance cost on borrowings - 3.60 0.00 0.00
6 Max Healthcare Institute Limited Alexis Multi-Speciality Hospital Private Limited Wholly - owned subsidiary Purchase of goods or services - 0.40 0.00 0.00
7 Max Healthcare Institute Limited Alexis Multi-Speciality Hospital Private Limited Wholly - owned subsidiary Sale of goods or services - 0.28 0.00 0.00
8 Max Healthcare Institute Limited Alexis Multi-Speciality Hospital Private Limited Wholly - owned subsidiary Any other transaction Healthcare services rendered - 24.30 0.00 0.00
9 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Any other transaction Medical Services rendered - 3.10 0.00 0.00
10 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Any other transaction Repayment of loans advances given to subsidiary - 275.00 0.00 0.00
11 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Advance - 0.00 0.00 0.00
12 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Interest received - 627.13 0.00 0.00
13 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Any other transaction Transfer of employee retire benefits -out - 0.00 0.00 0.00
14 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Any other transaction ESOP cross charge to subsidiary - 872.47 0.00 0.00
15 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Any other transaction Rental income - 2.27 0.00 0.00
16 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Any other transaction Sale of food & beverages - 115.94 0.00 0.00
17 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Sale of goods or services - 166.43 0.00 0.00
18 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Any other transaction Healthcare services rendered - 138.01 0.00 0.00
19 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Sale of goods or services - 0.00 0.00 0.00
20 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Purchase of goods or services - 0.50 0.00 0.00
21 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Any other transaction Medical services availed/provided under company managed employees group medical policy - 57.15 0.00 0.00
22 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Purchase of goods or services - 0.00 0.00 0.00
23 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Any other transaction Transfer of employee retire benefits -in - 3.82 0.00 0.00
24 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Any other transaction Lease rental expense - 0.90 0.00 0.00
25 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Repayment of loans advances given to subsidiary - 1,000.00 0.00 0.00 Textual Information(2)
26 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Interest received - 4,956.89 0.00 0.00 Textual Information(3)
27 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Operation and management fee - 1,316.21 0.00 0.00 Textual Information(4)
28 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Operation and management fee - 150.00 0.00 0.00 Textual Information(5)
29 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Sale of goods or services - 8.13 0.00 0.00 Textual Information(6)
30 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Healthcare services rendered - 462.73 0.00 0.00 Textual Information(7)
31 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Transfer of employee retire benefits -out - 1.31 0.00 0.00 Textual Information(8)
32 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Healthcare services rendered - 4,745.17 0.00 0.00 Textual Information(9)
33 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Unwinding of discount of security deposit - 3.43 0.00 0.00 Textual Information(10)
34 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Transfer of Employee Retire Benefits -In - 1.67 0.00 0.00 Textual Information(11)
35 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Medical Services rendered - 0.91 0.00 0.00 Textual Information(12)
36 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Lease rental expense - 1.04 0.00 0.00 Textual Information(13)
37 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Medical services availed/provided under company managed employees group medical policy - 44.25 0.00 0.00 Textual Information(14)
38 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Purchase of goods or services - 0.53 0.00 0.00 Textual Information(15)
39 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Healthcare services availed - 0.77 0.00 0.00 Textual Information(16)
40 Max Healthcare Institute Limited Dr. Balabhai Nanavati Hospital Deemed Subsidiary Any other transaction Unwinding of discount of security deposit - 61.14 0.00 0.00 Textual Information(17)
41 Max Healthcare Institute Limited Dr. Balabhai Nanavati Hospital Deemed Subsidiary Any other transaction Lease rental expense - 3.81 0.00 0.00 Textual Information(18)
42 Max Healthcare Institute Limited Dr. Balabhai Nanavati Hospital Deemed Subsidiary Sale of goods or services - 1.99 0.00 0.00 Textual Information(19)
43 Max Healthcare Institute Limited Dr. Balabhai Nanavati Hospital Deemed Subsidiary Any other transaction Transfer of employee retire benefits -in - 3.59 0.00 0.00 Textual Information(20)
44 Max Healthcare Institute Limited Dr. Balabhai Nanavati Hospital Deemed Subsidiary Any other transaction Medical services availed/provided under company managed employees group medical policy - 14.96 0.00 0.00 Textual Information(21)
45 Max Healthcare Institute Limited Dr. Balabhai Nanavati Hospital Deemed Subsidiary Any other transaction Reimbursement of Expenses - 0.00 0.00 0.00 Textual Information(22)
46 Max Healthcare Institute Limited Dr. Balabhai Nanavati Hospital Deemed Subsidiary Any other transaction Healthcare services rendered - 1,340.84 0.00 0.00 Textual Information(23)
47 Max Healthcare Institute Limited Dr. Balabhai Nanavati Hospital Deemed Subsidiary Any other transaction Healthcare services rendered - 37.92 0.00 0.00 Textual Information(24)
48 Max Healthcare Institute Limited Dr. Balabhai Nanavati Hospital Deemed Subsidiary Purchase of goods or services - 0.26 0.00 0.00 Textual Information(25)
49 Max Healthcare Institute Limited Dr. Balabhai Nanavati Hospital Deemed Subsidiary Any other transaction Transfer of Employee Retire Benefits -Out - 1.30 0.00 0.00 Textual Information(26)
50 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Medical Services rendered - 4.52 0.00 0.00
51 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Repayment of loans advances given to subsidiary - 0.00 0.00 0.00
52 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Interest received - 263.22 0.00 0.00
53 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Finance arrangement fee - 32.02 0.00 0.00
54 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction ESOP cross charge to subsidiary - 19.44 0.00 0.00
55 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Sale of goods or services - 16.92 0.00 0.00
56 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Sale of PPE - 1.49 0.00 0.00
57 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Healthcare services rendered - 526.67 0.00 0.00
58 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Transfer of employee retire benefits -in - 4.63 0.00 0.00
59 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Transfer of employee retire benefits -out - 0.31 0.00 0.00
60 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Healthcare services availed - 49.70 0.00 0.00
61 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Purchase of goods or services - 0.16 0.00 0.00
62 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Medical services availed/provided under company managed employees group medical policy - 44.01 0.00 0.00
63 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Lease rental expense - 39.22 0.00 0.00
64 Max Healthcare Institute Limited Eqova Healthcare Private Limited Subsidiary Any other transaction ESOP cross charge to subsidiary 50.00 - 21.88 0.00 0.00
65 Max Healthcare Institute Limited Eqova Healthcare Private Limited Subsidiary Any other transaction Rental income 4.00 - 1.94 0.00 0.00
66 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Dividend received - 0.00 0.00 0.00
67 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Any other transaction Transfer of Employee Retire Benefits -In - 3.10 0.00 0.00
68 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Any other transaction Transfer of Employee Retire Benefits -out - 0.80 0.00 0.00
69 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Any other transaction Repayment of borrowing taken from subsidiary - 1,000.00 0.00 0.00
70 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Any other transaction Rental income - 5.14 0.00 0.00
71 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Any other transaction ESOP cross charge to subsidiary - 10.85 0.00 0.00
72 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Any other transaction Healthcare services rendered - 276.05 0.00 0.00
73 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Purchase of goods or services - 0.37 0.00 0.00
74 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Sale of goods or services - 0.48 0.00 0.00
75 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Any other transaction Finance cost on borrowings - 452.49 0.00 0.00
76 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Any other transaction Medical services availed/provided under company managed employees group medical policy - 6.04 0.00 0.00
77 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Any other transaction Lease rental expense - 0.84 0.00 0.00
78 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Interest received - 163.76 0.00 0.00
79 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Purchase of goods or services - 7.52 0.00 0.00
80 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction ESOP cross charge to subsidiary - 21.35 0.00 0.00
81 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Transfer of employee retire benefits -in - 0.65 0.00 0.00
82 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Transfer of employee retire benefits -out - 0.57 0.00 0.00
83 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Lease rental expense - 1.52 0.00 0.00
84 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Finance arrangement fee - 469.86 0.00 0.00
85 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Sale of goods or services - 4.74 0.00 0.00
86 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Healthcare services rendered - 217.49 0.00 0.00
87 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Any other transaction Transfer of Employee Retire Benefits -Out - 4.21 0.00 0.00 Textual Information(27)
88 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Interest received - 535.40 0.00 0.00 Textual Information(28)
89 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Any other transaction Operation and management fee - 30.00 0.00 0.00 Textual Information(29)
90 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Any other transaction Medical services availed/provided under company managed employees group medical policy - 43.13 0.00 0.00 Textual Information(30)
91 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Any other transaction Loan given to subsidiaries - 2,000.00 0.00 0.00 Textual Information(31)
92 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Any other transaction Lease rental expense - 1.52 0.00 0.00 Textual Information(32)
93 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Sale of goods or services - 6,015.42 0.00 0.00 Textual Information(33)
94 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Purchase of goods or services - 0.00 0.00 0.00 Textual Information(34)
95 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Any other transaction Transfer of employee retire benefits -in - 0.00 0.00 0.00 Textual Information(35)
96 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Any other transaction Healthcare services rendered - 1,377.25 0.00 0.00 Textual Information(36)
97 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Any other transaction Unwinding of discount of security deposit - 229.74 0.00 0.00 Textual Information(37)
98 Max Healthcare Institute Limited Max Healthcare FZ-LLC Wholly - owned subsidiary Interest received - 0.00 0.00 0.00
99 Max Healthcare Institute Limited Max Healthcare FZ-LLC Wholly - owned subsidiary Investment - 0.00 0.00 0.00
100 Max Healthcare Institute Limited Max Healthcare FZ-LLC Wholly - owned subsidiary Any other transaction Repayment of loans advances given to subsidiary - 0.00 0.00 0.00
101 Max Healthcare Institute Limited Max Healthcare FZ-LLC Wholly - owned subsidiary Any other transaction Intermediary services-Reversal - (77.27) 0.00 0.00
102 Max Healthcare Institute Limited MHC Global Healthcare (Nigeria) Ltd Wholly - owned subsidiary Interest received - 0.00 0.00 0.00 Textual Information(38)
103 Max Healthcare Institute Limited MHC Global Healthcare (Nigeria) Ltd Wholly - owned subsidiary Any other transaction Repayment of loans advances given to subsidiary - 7.32 0.00 0.00 Textual Information(39)
104 Max Healthcare Institute Limited Max Healthcare Foundation Wholly - owned subsidiary Any other transaction Rental income - 1.94 0.00 0.00
105 Max Healthcare Institute Limited Max Healthcare Foundation Wholly - owned subsidiary Any other transaction CSR contribution - 75.50 0.00 0.00
106 Max Healthcare Institute Limited Max Lab Limited Wholly - owned subsidiary Sale of goods or services - 0.00 0.00 0.00
107 Max Healthcare Institute Limited Max Lab Limited Wholly - owned subsidiary Any other transaction Borrowings from subsidiaries - 1,000.00 0.00 0.00
108 Max Healthcare Institute Limited Max Lab Limited Wholly - owned subsidiary Any other transaction Finance cost on borrowings - 3.60 0.00 0.00
109 Max Healthcare Institute Limited Max Lab Limited Wholly - owned subsidiary Any other transaction Transfer of employee retire benefits -in - 0.00 0.00 0.00
110 Max Healthcare Institute Limited Max Lab Limited Wholly - owned subsidiary Any other transaction Medical services availed/provided under company managed employees group medical policy - 33.08 0.00 0.00
111 Max Healthcare Institute Limited Max Lab Limited Wholly - owned subsidiary Any other transaction ESOP cross charge to subsidiary - 9.89 0.00 0.00
112 Max Healthcare Institute Limited Max Lab Limited Wholly - owned subsidiary Any other transaction Rental income - 1.94 0.00 0.00
113 Max Healthcare Institute Limited Max Lab Limited Wholly - owned subsidiary Any other transaction Healthcare services rendered - 2,899.49 0.00 0.00
114 Max Healthcare Institute Limited Starlit Medical centre Private Limited Step down subsidiary Any other transaction Transfer of employee retire benefits -out - 0.00 0.00 0.00
115 Max Healthcare Institute Limited Starlit Medical centre Private Limited Step down subsidiary Any other transaction Medical services availed/provided under company managed employees group medical policy - 1.54 0.00 0.00
116 Max Healthcare Institute Limited Starlit Medical centre Private Limited Step down subsidiary Any other transaction ESOP cross charge to subsidiary - 26.99 0.00 0.00
117 Max Healthcare Institute Limited Starlit Medical centre Private Limited Step down subsidiary Purchase of goods or services - 0.28 0.00 0.00
118 Max Healthcare Institute Limited Starlit Medical centre Private Limited Step down subsidiary Any other transaction Finance arrangement fee - 319.41 0.00 0.00
119 Max Healthcare Institute Limited Starlit Medical centre Private Limited Step down subsidiary Sale of goods or services - 0.47 0.00 0.00
120 Max Healthcare Institute Limited Starlit Medical centre Private Limited Step down subsidiary Any other transaction Healthcare services rendered - 114.12 0.00 0.00
121 Max Healthcare Institute Limited Ms. Amrita Gangotra Director of listed entity Any other transaction Director sitting Fees - 9.00 0.00 0.00 Textual Information(40)
122 Max Healthcare Institute Limited Ms. Amrita Gangotra Director of listed entity Remuneration - 17.50 0.00 0.00 Textual Information(41)
123 Max Healthcare Institute Limited Mr. Anil Kumar Bhatnagar Director of listed entity Any other transaction Director sitting Fees - 6.00 0.00 0.00 Textual Information(42)
124 Max Healthcare Institute Limited Mr. Anil Kumar Bhatnagar Director of listed entity Remuneration - 17.50 0.00 0.00 Textual Information(43)
125 Max Healthcare Institute Limited Mr. Mahendra Gumanmalji Lodha Director of listed entity Any other transaction Director sitting Fees - 12.00 0.00 0.00 Textual Information(44)
126 Max Healthcare Institute Limited Mr. Mahendra Gumanmalji Lodha Director of listed entity Remuneration - 17.50 0.00 0.00 Textual Information(45)
127 Max Healthcare Institute Limited Mr. Michael Thomas Neeb Director of listed entity Any other transaction Director sitting Fees - 11.00 0.00 0.00 Textual Information(46)
128 Max Healthcare Institute Limited Mr. Michael Thomas Neeb Director of listed entity Remuneration - 17.50 0.00 0.00 Textual Information(47)
129 Max Healthcare Institute Limited Mr. Narayan K Seshadri Director of listed entity Any other transaction Director sitting Fees - 4.00 0.00 0.00 Textual Information(48)
130 Max Healthcare Institute Limited Mr. Narayan K Seshadri Director of listed entity Remuneration - 17.50 0.00 0.00 Textual Information(49)
131 Max Healthcare Institute Limited MR. Pranav C. Mehta Director of listed entity Any other transaction Director sitting Fees - 7.00 0.00 0.00 Textual Information(50)
132 Max Healthcare Institute Limited MR. Pranav C. Mehta Director of listed entity Remuneration - 17.50 0.00 0.00 Textual Information(51)
133 Max Healthcare Institute Limited Mr. Pranav Chirayu Amin Director of listed entity Any other transaction Director sitting Fees - 7.00 0.00 0.00 Textual Information(52)
134 Max Healthcare Institute Limited Mr. Pranav Chirayu Amin Director of listed entity Remuneration - 17.50 0.00 0.00 Textual Information(53)
135 Max Healthcare Institute Limited Mr. Narayan K Seshadri Director of listed entity Any other transaction Reimbursement of Expenses - 0.00 0.00 0.00 Textual Information(54)
136 Max Healthcare Institute Limited Ms. Amrita Gangotra Director of listed entity Any other transaction Reimbursement of Expenses - 0.00 0.00 0.00 Textual Information(55)
137 Max Healthcare Institute Limited Mr. Mahendra Gumanmalji Lodha Director of listed entity Any other transaction Reimbursement of Expenses - 0.00 0.00 0.00 Textual Information(56)
138 Max Healthcare Institute Limited MR. Pranav C. Mehta Director of listed entity Any other transaction Reimbursement of Expenses - 0.00 0.00 0.00 Textual Information(57)
139 Max Healthcare Institute Limited Yerawada Properties Private Limited Subsidiary Any other transaction Loan given to subsidiaries 12,500.00 - 445.00 0.00 0.00
140 Max Healthcare Institute Limited Kalinga Hospital Ltd Subsidiary Any other transaction Loan given to subsidiaries 10,000.00 - 650.00 0.00 0.00
141 Max Healthcare Institute Limited Kalinga Hospital Ltd Subsidiary Interest received 900.00 - 20.96 0.00 0.00
142 Max Healthcare Institute Limited Yerawada Properties Private Limited Subsidiary Interest received 850.00 - 5.85 0.00 0.00
143 Max Healthcare Institute Limited Kalinga Hospital Ltd Subsidiary Any other transaction Transfer of employee retire benefits -out 100.00 - 1.72 0.00 0.00
144 Max Healthcare Institute Limited Kalinga Hospital Ltd Subsidiary Any other transaction Subscription of right issue in subsidiary 25,000.00 - 8,787.12 0.00 0.00
145 Max Healthcare Institute Limited Alexis Multi-Speciality Hospital Private Limited Wholly - owned subsidiary Investment - 0.00 37,174.59 37,174.59
146 Max Healthcare Institute Limited Alexis Multi-Speciality Hospital Private Limited Wholly - owned subsidiary Any other transaction Repayment of Loan - 0.00 1,500.00 0.00 Advance 8.7500 5 years Unsecured For general corporate business purpose, repayment of debt, capital expenditure and business expansion
147 Max Healthcare Institute Limited Alexis Multi-Speciality Hospital Private Limited Wholly - owned subsidiary Any other transaction Borrowings from subsidiaries - 0.00 0.00 1,000.00 Loan 8.7500 5 years Unsecured For general corporate business purpose, repayment of debt, capital expenditure and business expansion
148 Max Healthcare Institute Limited Alexis Multi-Speciality Hospital Private Limited Wholly - owned subsidiary Any other transaction Trade receivables - 0.00 0.00 5.08
149 Max Healthcare Institute Limited Alexis Multi-Speciality Hospital Private Limited Wholly - owned subsidiary Any other transaction Trade payables - 0.00 6.74 16.57
150 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Any other transaction Employee stock option outstanding - 0.00 446.95 446.95
151 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Investment - 0.00 53,324.72 53,324.72
152 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Any other transaction Trade receivables - 0.00 44.04 30.06
153 Max Healthcare Institute Limited Alps Hospital Limited Wholly - owned subsidiary Any other transaction Loan including interest - 0.00 14,320.00 14,045.00 Advance 8.7500 10 years Unsecured For general corporate business purpose, repayment of debt, capital expenditure and business expansion
154 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Security deposit (discounted value) - 0.00 54.71 58.14 Textual Information(58)
155 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Loan - 0.00 16,855.64 15,855.64 Advance 10.600 5 years Unsecured For general corporate business purpose, repayment of debt, capital expenditure and business expansion Textual Information(59)
156 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Trade receivables - 0.00 3,441.07 1,675.16 Textual Information(60)
157 Max Healthcare Institute Limited Dr. B. L. Kapur Memorial Hospital Deemed Subsidiary Any other transaction Trade payables - 0.00 0.00 0.00 Textual Information(61)
158 Max Healthcare Institute Limited Dr. Balabhai Nanavati Hospital Deemed Subsidiary Any other transaction Security deposit (discounted value) - 0.00 766.34 800.07 Textual Information(62)
159 Max Healthcare Institute Limited Dr. Balabhai Nanavati Hospital Deemed Subsidiary Any other transaction Trade payables - 0.00 0.00 0.00 Textual Information(63)
160 Max Healthcare Institute Limited Dr. Balabhai Nanavati Hospital Deemed Subsidiary Any other transaction Trade receivables - 0.00 24.01 246.04 Textual Information(64)
161 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Employee stock option outstanding - 0.00 338.65 338.65
162 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Investment - 0.00 1,12,430.97 1,12,430.97
163 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Loan - 0.00 6,000.00 6,000.00 Advance 8.7500 5 years Unsecured For general corporate business purpose, repayment of debt, capital expenditure and business expansion
164 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Trade receivables - 0.00 37.96 193.81
165 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Trade payables - 0.00 0.00 37.54
166 Max Healthcare Institute Limited Eqova Healthcare Private Limited Subsidiary Any other transaction Employee stock option outstanding - 0.00 37.68 37.68
167 Max Healthcare Institute Limited Eqova Healthcare Private Limited Subsidiary Investment - 0.00 11,604.61 11,604.61
168 Max Healthcare Institute Limited Eqova Healthcare Private Limited Subsidiary Any other transaction Trade payables - 0.00 0.00 0.00
169 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Investment - 0.00 40,659.15 40,659.15
170 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Any other transaction Borrowings from subsidiaries - 0.00 10,850.00 9,850.00 Loan 8.7500 5 years Unsecured For general corporate business purpose, repayment of debt, capital expenditure and business expansion
171 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Any other transaction Employee stock option outstanding - 0.00 122.99 122.99
172 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Any other transaction Trade receivables - 0.00 12.94 44.17
173 Max Healthcare Institute Limited Hometrail Buildtech Private Limited Wholly - owned subsidiary Any other transaction Trade payables - 0.00 0.00 0.00
174 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Investment - 0.00 0.00 0.00
175 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Loan - 0.00 3,732.87 3,732.87 Advance 8.7500 5 years Unsecured For general corporate business purpose, repayment of debt, capital expenditure and business expansion
176 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Employee stock option outstanding - 0.00 0.00 0.00
177 Max Healthcare Institute Limited Crosslay Remedies Limited Wholly - owned subsidiary Any other transaction Trade receivables - 0.00 1,273.83 1,904.49
178 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Loan - 0.00 11,800.00 13,800.00 Advance 8.7500 5 years Unsecured For general corporate business purpose, repayment of debt, capital expenditure and business expansion Textual Information(65)
179 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Any other transaction Trade receivables - 0.00 8,760.04 7,495.76 Textual Information(66)
180 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Any other transaction Trade payables - 0.00 0.00 0.00 Textual Information(67)
181 Max Healthcare Institute Limited Muthoot Hospital Private Limited Deemed Subsidiary Any other transaction Security deposit (discounted value) - 0.00 5,029.36 5,259.11 Textual Information(68)
182 Max Healthcare Institute Limited Max Healthcare FZ-LLC Wholly - owned subsidiary Investment - 0.00 2,298.72 2,298.72
183 Max Healthcare Institute Limited Max Healthcare FZ-LLC Wholly - owned subsidiary Any other transaction Trade payables - 0.00 404.93 32.47
184 Max Healthcare Institute Limited MHC Global Healthcare (Nigeria) Ltd Wholly - owned subsidiary Investment - 0.00 192.76 192.76 Textual Information(69)
185 Max Healthcare Institute Limited MHC Global Healthcare (Nigeria) Ltd Wholly - owned subsidiary Loan - 0.00 133.55 121.99 Textual Information(70)
186 Max Healthcare Institute Limited Max Healthcare Foundation Wholly - owned subsidiary Any other transaction Trade receivables - 0.00 6.85 0.00
187 Max Healthcare Institute Limited Max Lab Limited Wholly - owned subsidiary Any other transaction Employee stock option outstanding - 0.00 36.54 36.54
188 Max Healthcare Institute Limited Max Lab Limited Wholly - owned subsidiary Investment - 0.00 4,000.00 4,000.00
189 Max Healthcare Institute Limited Max Lab Limited Wholly - owned subsidiary Any other transaction Borrowings from subsidiaries - 0.00 0.00 1,000.00 Loan 8.7500 5 years Unsecured For general corporate business purpose, repayment of debt, capital expenditure and business expansion
190 Max Healthcare Institute Limited Max Lab Limited Wholly - owned subsidiary Any other transaction Trade payables - 0.00 0.00 0.00
191 Max Healthcare Institute Limited Max Lab Limited Wholly - owned subsidiary Any other transaction Trade receivables - 0.00 683.47 471.86
192 Max Healthcare Institute Limited Mr. Michael Thomas Neeb Director of listed entity Any other transaction Trade payables - 0.00 0.00 0.66 Textual Information(71)
193 Max Healthcare Institute Limited MR. Pranav C. Mehta Director of listed entity Any other transaction Trade payables - 0.00 0.00 0.66 Textual Information(72)
194 Max Healthcare Institute Limited Starlit Medical centre Private Limited Step down subsidiary Any other transaction Trade receivables - 0.00 214.68 486.10
195 Max Healthcare Institute Limited Yerawada Properties Private Limited Subsidiary Loan - 0.00 0.00 445.00 Advance 9.00 5 years Unsecured For pre-payment of Equipment Loan, Pre-pay working capital loan and other general corporate purpose
196 Max Healthcare Institute Limited Kalinga Hospital Ltd Subsidiary Loan - 0.00 0.00 650.00 Advance 9.00 5 years Unsecured To meet project-related expenses and general corporate purposes
197 Max Healthcare Institute Limited Kalinga Hospital Ltd Subsidiary Any other transaction Trade payables - 0.00 0.00 1.72
198 Max Healthcare Institute Limited Kalinga Hospital Ltd Subsidiary Investment - 0.00 0.00 38,731.09
199 Max Healthcare Institute Limited Yerawada Properties Private Limited Subsidiary Investment - 0.00 0.00 8,792.00
200 Max Healthcare Institute Limited Mr. Abhay Soi Director & Key Managerial Personnel (Chairman & Managing Director) Remuneration - 1,995.90 0.00 0.00
201 Max Healthcare Institute Limited Mr. Yogesh Kumar Sareen Key Managerial Personnel Remuneration - 295.58 0.00 0.00 Textual Information(73)
202 Max Healthcare Institute Limited Mr. Dhiraj Arorra Key Managerial Personnel Remuneration - 70.47 0.00 0.00 Textual Information(74)
203 Max Healthcare Institute Limited Mr. Abhay Soi Director & Key Managerial Personnel (Chairman & Managing Director) Dividend paid 4,614.35 - 4,614.35 0.00 0.00 Textual Information(75)
204 Max Healthcare Institute Limited Col. Harinder Singh Chehal Director of subsidiary Dividend paid 6.74 - 6.74 0.00 0.00
205 Max Healthcare Institute Limited Mr. Yogesh Kumar Sareen Key Managerial Personnel Dividend paid 5.71 - 5.71 0.00 0.00
206 Max Healthcare Institute Limited Ms. Vandana Ramesh Pakle Director of subsidiary Dividend paid 4.98 - 4.98 0.00 0.00
207 Max Healthcare Institute Limited Mr. Anas Abdul Wajid Director of subsidiary Dividend paid 2.25 - 2.25 0.00 0.00
208 Max Healthcare Institute Limited Dr. Gaurav Aggarwal Director of subsidiary Dividend paid 1.81 - 1.81 0.00 0.00
209 Max Healthcare Institute Limited Dr. Mradul Kaushik Director of subsidiary Dividend paid 1.71 - 1.71 0.00 0.00
210 Max Healthcare Institute Limited Mr. Aditya Soi Relative of Chairman & Managing Director Dividend paid 1.20 - 1.20 0.00 0.00
211 Max Healthcare Institute Limited Mr.Gurpreet Singh Director of subsidiary Dividend paid 0.60 - 0.60 0.00 0.00
212 Max Healthcare Institute Limited Ms. Arpita Mukherjee Director of subsidiary Dividend paid 0.59 - 0.59 0.00 0.00
213 Max Healthcare Institute Limited Mr. Rakesh Dumir Director of subsidiary Dividend paid 0.59 - 0.59 0.00 0.00
214 Max Healthcare Institute Limited Mr.Sukhdeep Kaur Key Managerial Personnel of subsidiary Dividend paid 0.34 - 0.34 0.00 0.00
215 Max Healthcare Institute Limited Mr.Keshav Gupta Director of subsidiary Dividend paid 0.32 - 0.32 0.00 0.00
216 Max Healthcare Institute Limited Dr. Suhas Parnami Director of subsidiary Dividend paid 0.24 - 0.24 0.00 0.00
217 Max Healthcare Institute Limited Mr.Dhiraj Aroraa Key Managerial Personnel Dividend paid 0.16 - 0.16 0.00 0.00
218 Max Healthcare Institute Limited Mr.Kamal Lohani Director of subsidiary Dividend paid 0.03 - 0.03 0.00 0.00
219 Max Healthcare Institute Limited Mr. Sourabh Rastogi Key Managerial Personnel of subsidiary Dividend paid 0.00 - 0.00 0.00 0.00
220 Dr. B. L. Kapur Memorial Hospital Muthoot Hospital Private Limited Entities under same Group/common control Any other transaction Healthcare services rendered - 46.20 0.00 0.00
221 Dr. B. L. Kapur Memorial Hospital Dr. Balabhai Nanavati Hospital Entities under same Group/common control Any other transaction Healthcare services rendered - 6.53 0.00 0.00
222 Dr. B. L. Kapur Memorial Hospital ALPS Hospital Limited Entities under same Group/common control Any other transaction Healthcare services rendered - 0.35 0.00 0.00
223 Dr. B. L. Kapur Memorial Hospital Crosslay Remedies Limited Entities under same Group/common control Sale of goods or services - 0.46 0.00 0.00
224 Dr. B. L. Kapur Memorial Hospital ALPS Hospital Limited Entities under same Group/common control Sale of goods or services - 1.08 0.00 0.00
225 Dr. B. L. Kapur Memorial Hospital Starlit Medical Centre Private Limited Entities under same Group/common control Sale of goods or services - 0.27 0.00 0.00
226 Dr. B. L. Kapur Memorial Hospital Crosslay Remedies Limited Entities under same Group/common control Sale of goods or services - 0.49 0.00 0.00
227 Dr. B. L. Kapur Memorial Hospital Crosslay Remedies Limited Entities under same Group/common control Purchase of goods or services - 0.80 0.00 0.00
228 Dr. B. L. Kapur Memorial Hospital ALPS Hospital Limited Entities under same Group/common control Purchase of goods or services - 1.94 0.00 0.00
229 Dr. B. L. Kapur Memorial Hospital Crosslay Remedies Limited Entities under same Group/common control Purchase of goods or services - 0.05 0.00 0.00
230 Dr. B. L. Kapur Memorial Hospital Starlit Medical Centre Private Limited Entities under same Group/common control Purchase of goods or services - 0.08 0.00 0.00
231 Dr. B. L. Kapur Memorial Hospital Muthoot Hospital Private Limited Entities under same Group/common control Any other transaction Transfer of employee retire benefits -out - 0.83 0.00 0.00
232 Dr. B. L. Kapur Memorial Hospital Crosslay Remedies Limited Entities under same Group/common control Any other transaction Transfer of employee retire benefits -in - 1.32 0.00 0.00
233 Dr. B. L. Kapur Memorial Hospital Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Transfer of employee retire benefits -in - 0.66 0.00 0.00
234 Dr. B. L. Kapur Memorial Hospital ALPS Hospital Limited Entities under same Group/common control Any other transaction Unwinding of discount of security deposit - 39.13 0.00 0.00
235 Dr. B. L. Kapur Memorial Hospital Max Healthcare FZ-LLC Entities under same Group/common control Any other transaction Intermediary services-Reversal - (102.06) 0.00 0.00
236 Dr. B. L. Kapur Memorial Hospital ALPS Hospital Limited Entities under same Group/common control Any other transaction Medical services fees - 9,554.92 0.00 0.00
237 Alps Hospital Limited Starlit Medical Centre Private Limited Entities under same Group/common control Sale of goods or services - 0.45 0.00 0.00
238 Alps Hospital Limited Crosslay Remedies Limited Entities under same Group/common control Sale of goods or services - 3.58 0.00 0.00
239 Alps Hospital Limited Alexis Multi-Speciality Hospital Private Limited Entities under same Group/common control Sale of goods or services - 0.04 0.00 0.00
240 Alps Hospital Limited Hometrail Buildtech Private Limited Entities under same Group/common control Sale of goods or services - 0.34 0.00 0.00
241 Alps Hospital Limited Muthoot Hospital Private Limited Entities under same Group/common control Any other transaction Healthcare services rendered - 4,201.76 0.00 0.00
242 Alps Hospital Limited Dr. Balabhai Nanavati Hospital Entities under same Group/common control Any other transaction Healthcare services rendered - 1,260.91 0.00 0.00
243 Alps Hospital Limited Max Lab Limited Entities under same Group/common control Any other transaction Healthcare services rendered - 18.40 0.00 0.00
244 Alps Hospital Limited Crosslay Remedies Limited Entities under same Group/common control Any other transaction Rental income - 1.47 0.00 0.00
245 Alps Hospital Limited Dr. Balabhai Nanavati Hospital Entities under same Group/common control Interest received - 649.60 0.00 0.00
246 Alps Hospital Limited Crosslay Remedies Limited Entities under same Group/common control Purchase of goods or services - 0.01 0.00 0.00
247 Alps Hospital Limited Starlit Medical Centre Private Limited Entities under same Group/common control Purchase of goods or services - 0.79 0.00 0.00
248 Alps Hospital Limited Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Transfer of employee retire benefits -out - 1.32 0.00 0.00
249 Alps Hospital Limited Dr. Balabhai Nanavati Hospital Entities under same Group/common control Any other transaction Operation and management fee - 105.00 0.00 0.00
250 Alps Hospital Limited Dr. Balabhai Nanavati Hospital Entities under same Group/common control Any other transaction Lease rental expense - 0.63 0.00 0.00
251 Alps Hospital Limited Dr. Balabhai Nanavati Hospital Entities under same Group/common control Any other transaction Finance arrangement fee - 178.46 0.00 0.00
252 Alps Hospital Limited Max Healthcare FZ-LLC Entities under same Group/common control Any other transaction Intermediary services-Reversal - (10.45) 0.00 0.00
253 Crosslay Remedies Limited Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Loan given - 3,000.00 0.00 0.00
254 Crosslay Remedies Limited Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Repayment of loans advances given - 2,000.00 0.00 0.00
255 Crosslay Remedies Limited Hometrail Buildtech Private Limited Entities under same Group/common control Any other transaction Repayment of borrowings - 1,000.00 0.00 0.00
256 Crosslay Remedies Limited Max Lab Limited Entities under same Group/common control Any other transaction Healthcare services rendered - 428.71 0.00 0.00
257 Crosslay Remedies Limited Muthoot Hospital Private Limited Entities under same Group/common control Any other transaction Healthcare services rendered - 586.65 0.00 0.00
258 Crosslay Remedies Limited Max Lab Limited Entities under same Group/common control Any other transaction Pathology Services rendered - 124.90 0.00 0.00
259 Crosslay Remedies Limited Eqova Healthcare Private Limited Entities under same Group/common control Interest received 760.00 - 112.81 0.00 0.00
260 Crosslay Remedies Limited Starlit Medical Centre Private Limited Entities under same Group/common control Interest received - 1,391.55 0.00 0.00
261 Crosslay Remedies Limited Alexis Multi-Speciality Hospital Private Limited Entities under same Group/common control Purchase of goods or services - 0.50 0.00 0.00
262 Crosslay Remedies Limited Dr. Balabhai Nanavati Hospital Entities under same Group/common control Purchase of goods or services - 0.22 0.00 0.00
263 Crosslay Remedies Limited Hometrail Buildtech Private Limited Entities under same Group/common control Purchase of goods or services - 1.79 0.00 0.00
264 Crosslay Remedies Limited Alexis Multi-Speciality Hospital Private Limited Entities under same Group/common control Sale of goods or services - 1.46 0.00 0.00
265 Crosslay Remedies Limited Dr. Balabhai Nanavati Hospital Entities under same Group/common control Sale of goods or services - 1.28 0.00 0.00
266 Crosslay Remedies Limited Hometrail Buildtech Private Limited Entities under same Group/common control Any other transaction Finance cost on borrowings - 30.68 0.00 0.00
267 Crosslay Remedies Limited Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Finance arrangement fee - 15.31 0.00 0.00
268 Crosslay Remedies Limited Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Income From Renting of Medical Equipments - 0.01 0.00 0.00
269 Crosslay Remedies Limited Muthoot Hospital Private Limited Entities under same Group/common control Any other transaction Transfer of employee retire benefits -in - 1.10 0.00 0.00
270 Crosslay Remedies Limited Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Transfer of employee retire benefits -out - 1.03 0.00 0.00
271 Crosslay Remedies Limited Muthoot Hospital Private Limited Entities under same Group/common control Any other transaction Transfer of employee retire benefits -out - 0.66 0.00 0.00
272 Crosslay Remedies Limited Dr Sowjanya Agarwal Entities under same Group/common control Any other transaction Professional consultancy fee - 110.64 0.00 0.00 Textual Information(76)
273 Crosslay Remedies Limited Max Healthcare FZ-LLC Entities under same Group/common control Any other transaction Intermediary services-Reversal - (7.42) 0.00 0.00
274 Dr. Balabhai Nanavati Hospital Starlit Medical Centre Private Limited Entities under same Group/common control Sale of goods or services - 0.32 0.00 0.00
275 Dr. Balabhai Nanavati Hospital Hometrail Buildtech Private Limited Entities under same Group/common control Sale of goods or services - 0.04 0.00 0.00
276 Dr. Balabhai Nanavati Hospital Alexis Multi-Speciality Hospital Private Limited Entities under same Group/common control Sale of goods or services - 0.53 0.00 0.00
277 Dr. Balabhai Nanavati Hospital Starlit Medical Centre Private Limited Entities under same Group/common control Purchase of goods or services - 1.72 0.00 0.00
278 Dr. Balabhai Nanavati Hospital Hometrail Buildtech Private Limited Entities under same Group/common control Purchase of goods or services - 0.55 0.00 0.00
279 Dr. Balabhai Nanavati Hospital Max Lab Limited Entities under same Group/common control Any other transaction Pathology Services rendered - 203.82 0.00 0.00
280 Dr. Balabhai Nanavati Hospital Max Healthcare FZ-LLC Entities under same Group/common control Any other transaction Intermediary services-Reversal - (26.07) 0.00 0.00
281 Hometrail Buildtech Private Limited Starlit Medical Centre Private Limited Entities under same Group/common control Sale of goods or services - 0.08 0.00 0.00
282 Hometrail Buildtech Private Limited Alexis Multi-Speciality Hospital Private Limited Entities under same Group/common control Sale of goods or services - 0.06 0.00 0.00
283 Hometrail Buildtech Private Limited Max Lab Limited Entities under same Group/common control Any other transaction Healthcare services rendered - 131.78 0.00 0.00
284 MAX LAB LIMITED Alexis Multi-Speciality Hospital Private Limited Entities under same Group/common control Any other transaction Healthcare services availed - 6.50 0.00 0.00
285 MAX LAB LIMITED Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Healthcare services availed - 78.63 0.00 0.00
286 MAX LAB LIMITED Muthoot Hospital Private Limited Entities under same Group/common control Any other transaction Transfer of employee retire benefits -in - 0.63 0.00 0.00
287 Muthoot Hospital Private Limited Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Transfer of employee retire benefits -out - 0.12 0.00 0.00
288 Starlit Medical Centre Private Limited Max Healthcare FZ-LLC Entities under same Group/common control Any other transaction Intermediary services-Reversal - (7.18) 0.00 0.00
289 Dr. B. L. Kapur Memorial Hospital Alps Hospital Limited Entities under same Group/common control Any other transaction Security deposit (discounted value) - 0.00 784.35 823.48
290 Dr. B. L. Kapur Memorial Hospital Crosslay Remedies Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 0.00 2.88
291 Dr. B. L. Kapur Memorial Hospital ALPS Hospital Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 2,284.28 3,110.50
292 Dr. B. L. Kapur Memorial Hospital Max Healthcare FZ-LLC Entities under same Group/common control Any other transaction Trade payables - 0.00 454.38 44.47
293 Dr. B. L. Kapur Memorial Hospital Alexis Multi-Speciality Hospital Private Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 0.41 0.41
294 Dr. B. L. Kapur Memorial Hospital Crosslay Remedies Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 0.00 4.50
295 Dr. B. L. Kapur Memorial Hospital Crosslay Remedies Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 0.24 1.12
296 Dr. B. L. Kapur Memorial Hospital Muthoot Hospital Private Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 26.27 9.40
297 Dr. B. L. Kapur Memorial Hospital Dr. Balabhai Nanavati Hospital Entities under same Group/common control Any other transaction Trade receivables - 0.00 2.59 2.57
298 Dr. B. L. Kapur Memorial Hospital Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 0.00 0.66
299 Alps Hospital Limited Dr. Balabhai Nanavati Hospital Entities under same Group/common control Any other transaction Loan including interest - 0.00 20,000.00 19,650.00 Loan 6.500 15 years Secured Towards part financeing development of project / reimbursement of capex done
300 Alps Hospital Limited Crosslay Remedies Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 9.36 13.44
301 Alps Hospital Limited Muthoot Hospital Private Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 1,535.69 2,296.45
302 Alps Hospital Limited Dr. Balabhai Nanavati Hospital Entities under same Group/common control Any other transaction Trade receivables - 0.00 1,511.24 2,135.93
303 Alps Hospital Limited Dr. Balabhai Nanavati Hospital Entities under same Group/common control Any other transaction Security deposit (discounted value) - 0.00 993.69 1,054.10
304 Alps Hospital Limited Max Lab Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 7.21 1.10
305 Alps Hospital Limited Max Healthcare FZ-LLC Entities under same Group/common control Any other transaction Trade payables - 0.00 28.36 3.78
306 Crosslay Remedies Limited Eqova Healthcare Private Limited Entities under same Group/common control Any other transaction Loan including interest 7,760.00 - 0.00 2,500.00 2,601.53 Loan 9.00 5 years Unsecured For general corporate business purpose, repayment of debt, capital expenditure and business expansion
307 Crosslay Remedies Limited Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Loan including interest - 0.00 31,487.71 33,129.80 Loan 8.7500 5 years Unsecured For general corporate business purpose, repayment of debt, capital expenditure and business expansion
308 Crosslay Remedies Limited Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 84.66 100.67
309 Crosslay Remedies Limited Max Lab Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 112.69 91.83
310 Crosslay Remedies Limited Muthoot Hospital Private Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 252.51 106.71
311 Crosslay Remedies Limited Hometrail Buildtech Private Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 3.37 3.30
312 Crosslay Remedies Limited Dr. Balabhai Nanavati Hospital Entities under same Group/common control Any other transaction Trade receivables - 0.00 0.00 1.69
313 Crosslay Remedies Limited Alexis Multi-Speciality Hospital Private Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 0.00 0.69
314 Crosslay Remedies Limited Dr Sowjanya Agarwal Entities under same Group/common control Any other transaction Trade payables - 0.00 15.53 17.78 Textual Information(77)
315 Crosslay Remedies Limited Alexis Multi-Speciality Hospital Private Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 0.60 0.45
316 Crosslay Remedies Limited Max Healthcare FZ-LLC Entities under same Group/common control Any other transaction Trade payables - 0.00 35.82 8.07
317 Dr. Balabhai Nanavati Hospital Max Lab Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 62.86 32.42
318 Dr. Balabhai Nanavati Hospital Alexis Multi-Speciality Hospital Private Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 0.00 0.47
319 Dr. Balabhai Nanavati Hospital Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 0.13 1.61
320 Dr. Balabhai Nanavati Hospital Max Healthcare FZ-LLC Entities under same Group/common control Any other transaction Trade payables - 0.00 85.61 45.11
321 Dr. Balabhai Nanavati Hospital Hometrail Buildtech Private Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 0.00 0.54
322 Hometrail Buildtech Private Limited Max Lab Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 0.00 22.83
323 Hometrail Buildtech Private Limited Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 0.01 2.02
324 Hometrail Buildtech Private Limited Muthoot Hospital Private Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 0.00 1.12
325 Hometrail Buildtech Private Limited Alexis Multi-Speciality Hospital Private Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 0.00 0.07
326 MAX LAB LIMITED Alexis Multi-Speciality Hospital Private Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 1.38 1.15
327 MAX LAB LIMITED Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 19.57 14.10
328 Muthoot Hospital Private Limited Max Healthcare FZ-LLC Entities under same Group/common control Any other transaction Trade payables - 0.00 169.42 19.80
329 Muthoot Hospital Private Limited Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 0.18 0.12
330 Starlit Medical Centre Private Limited Alexis Multi-Speciality Hospital Private Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 0.00 0.69
331 Alps Hospital Limited Starlit Medical Centre Private Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 0.11 0.00
332 Alps Hospital Limited Alexis Multi-Speciality Hospital Private Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 2.59 0.00
333 Crosslay Remedies Limited Hometrail Buildtech Private Limited Entities under same Group/common control Any other transaction Borrowings - 0.00 1,000.00 0.00 Loan 8.7500 5 years Unsecured For general corporate business purpose, repayment of debt, capital expenditure and business expansion
334 Dr. Balabhai Nanavati Hospital Crosslay Remedies Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 0.68 0.00
335 Hometrail Buildtech Private Limited Dr.Simmardeep Singh Gill Director of subsidiary Any other transaction Reimbursement of Expenses - 0.00 0.00 0.00
336 Hometrail Buildtech Private Limited Crosslay Remedies Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 0.23 0.07
337 MAX LAB LIMITED Hometrail Buildtech Private Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 40.08 0.00
338 MAX LAB LIMITED Crosslay Remedies Limited Entities under same Group/common control Any other transaction Trade payables - 0.00 36.15 0.00
339 MAX LAB LIMITED Crosslay Remedies Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 1.00 0.00
340 Muthoot Hospital Private Limited Crosslay Remedies Limited Entities under same Group/common control Any other transaction Trade receivables - 0.00 101.33 0.00
341 Starlit Medical Centre Private Limited Max Healthcare FZ-LLC Entities under same Group/common control Any other transaction Trade receivables - 0.00 7.14 0.00
342 Kalinga Hospital Ltd Dr. Sita Kantha Dash Director of subsidiary Any other transaction Finance cost on borrowings - 79.92 0.00 0.00 Textual Information(78)
343 Kalinga Hospital Ltd Dr. Sita Kantha Dash Director of subsidiary Any other transaction Loan including interest - 0.00 0.00 4,351.09 Loan 5.00 5 and 10 years Unsecured To meet capital and revenue expenditure
344 Dr. Balabhai Nanavati Hospital Mr.Prabhakar Kadulkar Relative of Director Any other transaction Healthcare services rendered 50.00 - 2.05 0.00 0.00 Textual Information(79)
345 Dr. Balabhai Nanavati Hospital Mr. ABHAY SOI Key Managerial Personnel Any other transaction Healthcare services rendered 50.00 - 0.23 0.00 0.00 Textual Information(80)
346 Dr. Balabhai Nanavati Hospital Mr. ADITYA SOI Relative of Chairman & Managing Director Any other transaction Healthcare services rendered 50.00 - 0.19 0.00 0.00 Textual Information(81)
347 Dr. Balabhai Nanavati Hospital Mrs. TARUNA SOI Relative of Chairman & Managing Director Any other transaction Healthcare services rendered 50.00 - 0.08 0.00 0.00 Textual Information(82)
348 Dr. Balabhai Nanavati Hospital Mrs. BULBUL SOI Relative of Chairman & Managing Director Any other transaction Healthcare services rendered 50.00 - 0.18 0.00 0.00 Textual Information(83)
349 Dr. Balabhai Nanavati Hospital Ms. DEVINA SOI Relative of Chairman & Managing Director Any other transaction Healthcare services rendered 50.00 - 0.09 0.00 0.00 Textual Information(84)
350 Dr. Balabhai Nanavati Hospital Ms. AESHANI SOI Relative of Chairman & Managing Director Any other transaction Healthcare services rendered 50.00 - 0.18 0.00 0.00 Textual Information(85)
351 Dr. Balabhai Nanavati Hospital Mrs. GAURI SOI Relative of Chairman & Managing Director Any other transaction Healthcare services rendered 50.00 - 0.23 0.00 0.00 Textual Information(86)
352 Dr. Balabhai Nanavati Hospital Ms. HINAYA SOI Relative of Chairman & Managing Director Any other transaction Healthcare services rendered 50.00 - 3.24 0.00 0.00 Textual Information(87)
353 Starlit Medical centre Private Limited Dr. Gaurav Aggarwal Key Managerial Personnel Any other transaction Security deposit accepted as per company’s car policy for employees - 3.47 0.00 3.47 Textual Information(88)
354 Max Healthcare Institute Limited Mr. Yogesh Kumar Sareen Key Managerial Personnel Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 9.51 9.51 Textual Information(89)
355 Max Healthcare Institute Limited Mr. Dhiraj Arorra Key Managerial Personnel Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 3.60 3.60 Textual Information(90)
356 Crosslay Remedies Limited Ms. Simran Kaur Key Managerial Personnel of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 1.50 1.50 Textual Information(91)
357 Muthoot Hospital Private Limited Ms. Arpita Mukherjee Director of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 3.80 3.80 Textual Information(92)
358 Crosslay Remedies Limited Dr. Gaurav Aggarwal Director of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 23.00 23.00 Textual Information(93)
359 Max Healthcare Institute Limited Mr. Mradul Kaushik Director of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 4.91 4.91 Textual Information(94)
360 Max Healthcare Institute Limited Ms. Vandana Ramesh Pakle Director of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 2.43 2.43 Textual Information(95)
361 Max Healthcare Institute Limited Mr. Harinder Singh Chehal Director of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 14.25 14.25 Textual Information(96)
362 Max Healthcare Institute Limited Mr. Anas Wajid Abdul Director of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 17.00 17.00 Textual Information(97)
363 Max Healthcare Institute Limited Mr. Suhas Parnami Director of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 2.54 2.54 Textual Information(98)
364 Alps Hospital Limited Mr. Gaurav Kumar Key Managerial Personnel of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 1.46 1.46 Textual Information(99)
365 Crosslay Remedies Limited Mr. Umang Jaiswal Key Managerial Personnel of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 1.66 1.66 Textual Information(100)
366 Hometrail Buildtech Private Limited Mr. Pankaj Sharma Key Managerial Personnel of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 1.40 1.40 Textual Information(101)
367 Max Lab Limited Mr. Sourabh Rastogi Key Managerial Personnel of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 1.92 1.92 Textual Information(102)
368 Max Lab Limited Mr. Swapnil Soni Key Managerial Personnel of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 4.00 4.00 Textual Information(103)
369 Max Lab Limited Mr. Arpan Malhotra Director of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 10.00 10.00 Textual Information(104)
370 Hometrail Buildtech Private Limited Dr.Simmardeep Singh Gill Director of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 10.50 10.50 Textual Information(105)
371 Starlit Medical centre Private Limited Mr. Pramit Mishra Director of subsidiary Any other transaction Security deposit accepted as per company’s car policy for employees - 0.00 2.98 2.98 Textual Information(106)
Total value of transaction during the reporting period 79,648.66



Text Block

Textual Information(1) 1. All transactions with related parties are excluding of taxes and are made on terms equivalent to those that prevail in arm's length transactions. 2. The value of the related party transaction denotes the amount approved by the Audit Committee/ Board of Directors of the Company, as applicable, for financial year 2026-27. 3. Investment and loan given (including interest due thereon) to subsidiary 'MHC Global Healthcare (Nigeria) Ltd' has been provided for in the books of accounts on account of liquidation. 4. Foreign subsidiary/national and minors does not have PAN. 5.
Textual Information(2) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(3) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(4) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(5) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(6) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(7) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(8) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(9) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(10) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(11) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(12) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(13) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(14) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(15) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(16) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(17) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(18) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(19) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(20) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(21) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(22) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(23) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(24) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(25) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(26) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(27) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(28) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(29) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(30) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(31) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(32) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(33) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(34) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(35) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(36) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(37) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(38) Investment and loan given (including interest due thereon) to subsidiary 'MHC Global Healthcare (Nigeria) Ltd' has been provided for in the books of accounts on account of liquidation.
Textual Information(39) Investment and loan given (including interest due thereon) to subsidiary 'MHC Global Healthcare (Nigeria) Ltd' has been provided for in the books of accounts on account of liquidation.
Textual Information(40) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(41) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(42) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(43) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(44) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(45) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(46) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(47) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(48) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(49) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(50) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(51) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(52) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(53) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(54) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(55) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(56) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(57) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(58) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(59) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(60) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(61) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(62) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(63) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(64) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(65) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(66) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(67) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(68) Entity where company has contractual arrangements ('silo' or 'deemed subsidiary')
Textual Information(69) Investment and loan given (including interest due thereon) to subsidiary 'MHC Global Healthcare (Nigeria) Ltd' has been provided for in the books of accounts on account of liquidation.
Textual Information(70) Investment and loan given (including interest due thereon) to subsidiary 'MHC Global Healthcare (Nigeria) Ltd' has been provided for in the books of accounts on account of liquidation.
Textual Information(71) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(72) Remuneration and sitting fees paid by the listed entity or its subsidiary to its director, key managerial personnel or senior management, except who is part of promoter or promoter group, shall not require approval of the audit committee provided that the same is not material in terms of the provisions of regulation 23 (i) of SEBI LODR.
Textual Information(73) As per approval given by Nomination & Remuneration Committee/Board of Directors/Shareholders, as may be applicable.
Textual Information(74) As per approval given by Nomination & Remuneration Committee/Board of Directors/Shareholders, as may be applicable.
Textual Information(75) As per approval given by Nomination & Remuneration Committee/Board of Directors/Shareholders, as may be applicable.
Textual Information(76) As per approval given by Nomination & Remuneration Committee/Board of Directors/Shareholders, as may be applicable.
Textual Information(77) As per approval given by Nomination & Remuneration Committee/Board of Directors/Shareholders, as may be applicable.
Textual Information(78) Transaction amount represent for the period post date of acquision date.
Textual Information(79) Aggregate of INR 150 Lakhs with maximum amount of INR 50 Lakhs for single party
Textual Information(80) Aggregate of INR 150 Lakhs with maximum amount of INR 50 Lakhs for single party
Textual Information(81) Aggregate of INR 150 Lakhs with maximum amount of INR 50 Lakhs for single party
Textual Information(82) Aggregate of INR 150 Lakhs with maximum amount of INR 50 Lakhs for single party
Textual Information(83) Aggregate of INR 150 Lakhs with maximum amount of INR 50 Lakhs for single party
Textual Information(84) Aggregate of INR 150 Lakhs with maximum amount of INR 50 Lakhs for single party
Textual Information(85) Aggregate of INR 150 Lakhs with maximum amount of INR 50 Lakhs for single party
Textual Information(86) Aggregate of INR 150 Lakhs with maximum amount of INR 50 Lakhs for single party
Textual Information(87) Aggregate of INR 150 Lakhs with maximum amount of INR 50 Lakhs for single party
Textual Information(88) As per company HR policy
Textual Information(89) As per company HR policy
Textual Information(90) As per company HR policy
Textual Information(91) As per company HR policy
Textual Information(92) As per company HR policy
Textual Information(93) As per company HR policy
Textual Information(94) As per company HR policy
Textual Information(95) As per company HR policy
Textual Information(96) As per company HR policy
Textual Information(97) As per company HR policy
Textual Information(98) As per company HR policy
Textual Information(99) As per company HR policy
Textual Information(100) As per company HR policy
Textual Information(101) As per company HR policy
Textual Information(102) As per company HR policy
Textual Information(103) As per company HR policy
Textual Information(104) As per company HR policy
Textual Information(105) As per company HR policy
Textual Information(106) As per company HR policy